Related Experiment Video

Updated: Aug 7, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma

Santanu Dasgupta1, Pulak K Tripathi, Hongxing Qin

  • 1Department of Internal Medicine, the Barrett Cancer Center, University of Cincinnati, Cincinnati, OH 45267, USA.

Oral Oncology
|December 3, 2005
PubMed

Insights

Researchers identified seven genes overexpressed in head and neck squamous cell carcinoma (HNSCC) tumors. Five of these genes, AREG, CDH3, KLK10, NmU, and SLPI, were also found at the protein level, indicating potential immunotherapy targets for HNSCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunotherapy

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is a significant global health concern.
  • Identifying novel molecular targets is crucial for developing effective immunotherapies for HNSCC.

Purpose of the Study:

  • To identify and validate novel molecular targets for HNSCC immunotherapy.
  • To analyze gene and protein expression profiles in HNSCC tumors compared to normal tissues.

Main Methods:

  • Gene expression profiling using microarray and real-time RT-PCR.
  • Screening of cell lines and normal human tissues to identify overexpressed genes.
  • Immunohistochemistry to confirm protein expression in tumor samples.

Main Results:

  • Seven genes (AREG, CDH3, KLK10, NmU, SLPI, ANAX3, MAL2) were identified with at least 10-fold overexpression in tumors versus normal tissues.
  • mRNA expression of these genes was at least 20-fold higher in HNSCC primary tumors.
  • AREG, CDH3, KLK10, NmU, and SLPI proteins were highly expressed in supraglottic laryngeal cancer specimens.

Conclusions:

  • The identified genes and their corresponding proteins represent promising molecular targets for HNSCC immunotherapy.
  • Further investigation into these targets could lead to the development of new therapeutic strategies for HNSCC patients.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...